Home › Compare › TNPH vs JEPQ

TNPH vs JEPQ: Dividend Comparison 2026

TNPH yields 19230.77% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TNPH wins by $35559072563224756224.00M in total portfolio value
10 years
TNPH
TNPH
● Live price
19230.77%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35559072563224756224.00M
Annual income
$35,199,015,251,958,400,000,000,000.00
Full TNPH calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — TNPH vs JEPQ

📍 TNPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTNPHJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TNPH + JEPQ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
TNPH pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TNPH
Annual income on $10K today (after 15% tax)
$1,634,615.38/yr
After 10yr DRIP, annual income (after tax)
$29,919,162,964,164,640,000,000,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, TNPH beats the other by $29,919,162,964,164,640,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TNPH + JEPQ for your $10,000?

TNPH: 50%JEPQ: 50%
100% JEPQ50/50100% TNPH
Portfolio after 10yr
$17779536281612378112.00M
Annual income
$17,599,507,625,979,200,000,000,000.00/yr
Blended yield
98.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TNPH buys
0
JEPQ buys
0
No recent congressional trades found for TNPH or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTNPHJEPQ
Forward yield19230.77% ✓11.10%
Annual dividend / share$2.00$6.16 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$35559072563224756224.00M ✓$44.8K
Annual income after 10y$35,199,015,251,958,400,000,000,000.00 ✓$2,152.59
Total dividends collected$35535307211105599488.00M ✓$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: TNPH vs JEPQ ($10,000, DRIP)

YearTNPH PortfolioTNPH Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$1,933,777$1,923,076.92$11,930$1,110.39+$1.92M → TNPH
2$349,620,709$347,551,567.77$14,133$1,224.34+$349.61M → TNPH
3$59,099,530,219$58,725,436,060.68$16,632$1,340.46+$59099.51M → TNPH
4$9,340,702,082,592$9,277,465,585,257.05$19,454$1,457.97+$9340702.06M → TNPH
5$1,380,374,723,530,610$1,370,380,172,302,236.20$22,626$1,576.08+$1380374723.51M → TNPH
6$190,743,943,336,084,320$189,266,942,381,906,560.00$26,175$1,694.09+$190743943336.06M → TNPH
7$24,646,546,669,772,927,000$24,442,450,650,403,320,000.00$30,133$1,811.32+$24646546669772.90M → TNPH
8$2,978,031,531,272,736,000,000$2,951,659,726,336,079,400,000.00$34,531$1,927.17+$2978031531272736.00M → TNPH
9$336,502,160,062,018,500,000,000$333,315,666,323,556,700,000,000.00$39,403$2,041.08+$336502160062018496.00M → TNPH
10$35,559,072,563,224,757,000,000,000$35,199,015,251,958,400,000,000,000.00$44,787$2,152.59+$35559072563224756224.00M → TNPH

TNPH vs JEPQ: Complete Analysis 2026

TNPH — Stock

Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company's pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chinese medicine preparation that is used to cure and treat prostate gland proliferation; Nizhuanle Yin granule, a Chinese medicine preparation that treats the decomposition or inflammation of the stomach's mucous membrane; and Tianan soft capsule, which is used to adjust high amounts of fat in the blood stream, improve blood vessel ventilation, and soften blood vessels. Its products also include Tianan Pain Relief Capsule, a Chinese medicine preparation, which is under development to cure pain in joints, headache, pain from muscle injury, cancer, and gynecological disorders, as well as general pain. Tian' An Pharmaceutical sells its products to independent distributors, who sell products to pharmacies and drugstores, and hospitals. The company was founded in 2003 and is based in Xi'an, China.

Full TNPH Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this TNPH vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TNPH vs SCHDTNPH vs JEPITNPH vs OTNPH vs KOTNPH vs MAINTNPH vs XYLDTNPH vs QYLDTNPH vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.